Refeyn launches MyMass instrument to simplify sample quality assessment for structural biology

2 hours ago 2

Article content

Compact, all-in-one mass photometer helps researchers verify sample quality before proceeding to cryo-EM, native MS, BLI, SPR, and other costly experiments

Financial Post

THIS CONTENT IS RESERVED FOR SUBSCRIBERS ONLY

Subscribe now to read the latest news in your city and across Canada.

  • Exclusive articles from Barbara Shecter, Joe O'Connor, Gabriel Friedman, and others.
  • Daily content from Financial Times, the world's leading global business publication.
  • Unlimited online access to read articles from Financial Post, National Post and 15 news sites across Canada with one account.
  • National Post ePaper, an electronic replica of the print edition to view on any device, share and comment on.
  • Daily puzzles, including the New York Times Crossword.

SUBSCRIBE TO UNLOCK MORE ARTICLES

Subscribe now to read the latest news in your city and across Canada.

  • Exclusive articles from Barbara Shecter, Joe O'Connor, Gabriel Friedman and others.
  • Daily content from Financial Times, the world's leading global business publication.
  • Unlimited online access to read articles from Financial Post, National Post and 15 news sites across Canada with one account.
  • National Post ePaper, an electronic replica of the print edition to view on any device, share and comment on.
  • Daily puzzles, including the New York Times Crossword.

REGISTER / SIGN IN TO UNLOCK MORE ARTICLES

Create an account or sign in to continue with your reading experience.

  • Access articles from across Canada with one account.
  • Share your thoughts and join the conversation in the comments.
  • Enjoy additional articles per month.
  • Get email updates from your favourite authors.

THIS ARTICLE IS FREE TO READ REGISTER TO UNLOCK.

Create an account or sign in to continue with your reading experience.

  • Access articles from across Canada with one account
  • Share your thoughts and join the conversation in the comments
  • Enjoy additional articles per month
  • Get email updates from your favourite authors

Sign In or Create an Account

or

Article content

OXFORD, United Kingdom, March 18, 2026 (GLOBE NEWSWIRE) — Refeyn, developer of pioneering mass photometry technology, announces the launch of MyMass™ mass photometer (MyMassMP), a compact instrument designed to answer a critical research question: Is the sample good enough for further analysis?

Article content

Article content

Structure-based drug design and AI-driven therapeutic development are transforming how new medicines are discovered, but depend on high-quality samples. Structural and biophysical workflows, such as cryo-EM, native mass spectrometry (MS), bio-layer interferometry (BLI), and surface plasmon resonance (SPR), are time-consuming and costly, and poor sample quality remains one of the main reasons they fail. MyMassMP gives researchers a fast, accurate assessment of purity, homogeneity, and oligomerization state in solution before committing to resource-intensive experiments.

Article content

Article content

Built on the same proven technology as Refeyn’s TwoMP mass photometer, which is already trusted across leading structural biology and biotherapeutics labs worldwide, MyMassMP brings this quality check capability into a simpler, self-contained benchtop instrument. Featuring an integrated display and computer for onboard data analysis, and dedicated consumables, it offers an intuitive workflow from sample to result.

Article content

By signing up you consent to receive the above newsletter from Postmedia Network Inc.

Article content

“Structural biology and AI-driven drug discovery are moving fast, but they’re only as good as the samples that drive them. MyMass directly addresses that challenge and marks a significant step forward for Refeyn, putting the power of mass photometry within reach of more researchers than ever before,” said Gerry Mackay, Refeyn CEO.

Article content

Fiona Coats, Chief Product and Marketing Officer at Refeyn, said: “In recent years, our users have consistently shown us how valuable mass photometry is for quickly assessing sample quality before committing to more complex experiments. With MyMassMP, we’re making this capability even more accessible – empowering researchers to confidently answer a simple but critical question: Are my samples ready?

Article content

Article content

MyMassMP is available now. Learn more at: refeyn.com/mymass

Article content

Is your sample ready? Introducing MyMass™: Is your sample ready? Introducing MyMass™ – Refeyn's newest mass photometer, designed to give structural biologists confidence in their sample before committing to cryo-EM or native MS.

Article content

Article content

About Refeyn

Article content

Refeyn (www.refeyn.com) specializes in the development, production, and distribution of mass photometry for industry and academia. Enabling accurate mass measurement of single molecules in their native state, and without labels, Refeyn’s products deliver crucial analytics faster and use less sample than conventional methods. The company’s vision is to accelerate discovery through innovation, empowering the latest scientific breakthroughs in basic research and transforming biotherapeutic development and manufacturing.

Article content

Contact:

Article content

Catie Lichten – Scientific Communications Manager
[email protected]

Article content

Article content

Article content

Article content

Article content

Article content

Read Entire Article